Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...

Amgen outperformed expectations in the fourth quarter of 2024, but revealed an FDA hold on early-stage obesity asset AMG 513 ...

Product sales rose 11%, led by 14% volume growth. Products including Repatha, Blincyto and Tezspire all posted at least double digit sales growth, the company said. For the current year, Amgen expects ...

Amgen Inc. (AMGN) on Tuesday reported fourth-quarter profit of $627 million. The Thousand Oaks, California-based company said it had ...

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...

“Medicines manufactured here in Holly Springs will help families worldwide. Think about that for a second.” In 2021, Amgen received state and local incentives to establish its drug substance ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...